About Stansberry Venture Technology
In Stansberry Venture Technology, Dave Lashmet scours the public markets for little-known, small-cap companies that are producing the next wonder drug or technology. And you can access these opportunities even if you’re not a millionaire or a venture capitalist.
Dave is the perfect man to head up this effort. He is extremely plugged in to the technology and biotech sector. He’s an inventor with three active patents. He has developed, packaged, and sold his ideas to one of the largest consumer-electronics firms in the world.
He has also spent the last 20-plus years working as an independent technology analyst, and close to a decade researching and writing about technology at five major universities.
In Stansberry Venture Technology, Dave searches for the smallest and most promising firms out there… ones you’d likely never hear about (that is, until they get acquired). The goal is for subscribers to make five or 10 times their money on these speculations.
Lower
Higher
– James E. Subscriber of Stansberry Venture Technology
Any Single Stock in this Portfolio Could Save Your Retirement
HERE’S HOW TO GET STARTED
At Stansberry Venture Technology, we take an approach to investing that is responsible for some of the biggest investment gains in history.
We approach the market as venture capitalists.
Venture capitalists are the home run hitters of investing. They are the early backers in startup companies. Their successes become front-page news.
For example…
Before you even heard about Apple, venture capitalists were making early investments. By the time regular stock market investors heard about the company, venture capitalists had made more than 80,000% on their original investments. That’s a gain that turns every $10,000 invested into $8 million.
At Stansberry Venture Technology, we’re doing something similar with one key difference…
Instead of recommending one big bet, we recommend lots of small bets across a dozen or more small, public companies with breakthrough products – the kind that could transform entire industries… and potentially return five to 10 times your money.
The stocks in this model portfolio are volatile… but if you can withstand occasional losses along the way, their moves can come up fast and be bigger than you’d ever imagine… just one big winner can make your retirement.
In fact, since we launched Venture Technology, more than 20 individual recommendations in the portfolio have doubled (or nearly doubled).
How do we find such big opportunities?
The secret is editor Dave Lashmet. Dave visits company headquarters and meets with CEOs, lab scientists, computer programmers – you name it – asking hundreds of questions to find the whole story.
The result is Stansberry Venture Technology – our most sophisticated research service.
If a hedge fund produced the kinds of gains we’re targeting… it would likely take $15,000 to $20,000 from your investments to pay for their fees and expenses.
But we wanted to make our research more accessible, so Stansberry Venture Technology costs just $5,500 per year. It’s a great deal, considering you’ll have the opportunity to turn hundreds into thousands.
Here’s what you’ll get with your subscription:
The Stansberry Venture Technology Handbook. This comprehensive guide will tell you everything you need to know about our investing philosophy.
Special Readers-Only Reports: In these in-depth guides, Dave reveals incredible opportunities and shares expert advice from the world of venture tech investing. You can immediately download these reports on our website the moment you gain access to Stansberry Venture Technology.
12 Monthly Stansberry Venture Technology Issues: This is where you’ll find Dave’s concise explanations of the latest happenings in venture investing, and the best ways to exploit the unique profit opportunities.
The Stansberry Digest: Every weekday, the Stansberry Research editorial team writes up notes on interesting situations taking shape in the markets. This daily e-letter will keep you up-to-date on what’s going on with the Stansberry Research family: what we got right… what we got wrong… what we have planned… and more.